KINEVANT SCIENCES HOLDINGS LIMITED

Active London

Activities of other holding companies n.e.c.

2 employees website.com
Activities of other holding companies n.e.c.
K

KINEVANT SCIENCES HOLDINGS LIMITED

Activities of other holding companies n.e.c.

Founded 10 Dec 2018 Active London, United Kingdom 2 employees website.com
Activities of other holding companies n.e.c.

Previous Company Names

PHARMAVANT 2 HOLDINGS LTD. 10 Dec 2018 — 8 Jan 2019
Accounts Submitted 3 Jul 2025 Next due 30 Jun 2026 2 months remaining
Confirmation Submitted 23 Dec 2025 Next due 23 Dec 2026 8 months remaining
Net assets £-51K £33K 2023 year on year
Total assets £94K £17K 2023 year on year
Total Liabilities £145K £16K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

7th Floor 50 Broadway London SW1H 0DB United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for KINEVANT SCIENCES HOLDINGS LIMITED (11719960), an active company based in London, United Kingdom. Incorporated 10 Dec 2018. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2019–2023)

Cash in Bank

N/A

Net Assets

-£51.34k

Decreased by £33.28k (-184%)

Total Liabilities

£145.12k

Increased by £16.20k (+13%)

Turnover

N/A

Employees

2

Debt Ratio

155%

Increased by 39 (+34%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 3 Shares £200k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
31 Mar 20251$105k$105k
31 Mar 20211$50k$50k
30 Mar 20201$45k$45k

Officers

Officers

2 active 1 resigned
Status
Lee Francis MooreDirectorBritishUnited Kingdom455 Aug 2022Active
Vistra Cosec LimitedCorporate-secretaryUnknownUnknown10 Dec 2018Active

Shareholders

Shareholders (1)

Kinevant Sciences Ltd
100.0%
20,563

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Roivant Sciences Ltd.

Bermuda

Active
Notified 1 Oct 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

KINEVANT SCIENCES HOLDINGS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Apr 2026OfficersChange to director Ms Emma Carys Price on 2026-04-01
31 Mar 2026OfficersChange Corporate Secretary Company With Change Date
23 Dec 2025Confirmation StatementConfirmation statement made on 2025-12-09 with updates
23 Dec 2025Persons With Significant ControlChange to Roivant Sciences Ltd. as a person with significant control on 2025-12-22
3 Jul 2025AccountsAnnual accounts made up to 2025-03-31
10 Apr 2026 Officers

Change to director Ms Emma Carys Price on 2026-04-01

31 Mar 2026 Officers

Change Corporate Secretary Company With Change Date

23 Dec 2025 Confirmation Statement

Confirmation statement made on 2025-12-09 with updates

23 Dec 2025 Persons With Significant Control

Change to Roivant Sciences Ltd. as a person with significant control on 2025-12-22

3 Jul 2025 Accounts

Annual accounts made up to 2025-03-31

Recent Activity

Latest Activity

Change to director Ms Emma Carys Price on 2026-04-01

1 weeks ago on 10 Apr 2026

Change Corporate Secretary Company With Change Date

3 weeks ago on 31 Mar 2026

Confirmation statement made on 2025-12-09 with updates

4 months ago on 23 Dec 2025

Change to Roivant Sciences Ltd. as a person with significant control on 2025-12-22

4 months ago on 23 Dec 2025

Annual accounts made up to 2025-03-31

9 months ago on 3 Jul 2025